Page 114 - Read Online
P. 114

Alipov et al. Vessel Plus 2017;1:107-15                                           Vessel Plus
           DOI: 10.20517/2574-1209.2017.20
                                                                                                  www.vpjournal.net
            Topic: Atherosclerosis and Related Diseases                                         Open Access

           Chemical composition of circulating native

           and desialylated low density lipoprotein:

           what is the difference?



           Vladimir I. Alipov , Vasily N. Sukhorukov , Vasily P. Karagodin , Andrey V. Grechko , Alexander N. Orekhov 1,4
                                                                                    3
                                              1,2
                          1
                                                                  1
           1 Laboratory of Angiopathology, Institute of General Pathology and Pathophysiology, 125315 Moscow, Russia.
           2 INSERM UMR_S 1166, Faculty of Medicine Pitie-Salpetriere, Bld de L’Hopital 91, University of Pierre and Marie Curie-Paris 6, 75013 Paris, France.
           3 Federal Scientific Clinical Center for Resuscitation and Rehabilitation, 109240 Moscow, Russia.
           4 Institute for Atherosclerosis Research, Skolkovo Innovative Center, 121609 Moscow, Russia.
           Correspondence to: Mr. Vasily N. Sukhorukov, INSERM UMR_S 1166, Faculte de Medecine Pitie-Salpetriere, Bld de L’Hopital 91, University of Pierre
           and Marie Curie - Paris 6, 75013 Paris, France. E-mail: vnsukhorukov@gmail.com
           How to cite this article: Alipov VI, Sukhorukov VN, Karagodin VP, Grechko AV, Orekhov AN. Chemical composition of circulating native and
           desialylated low density lipoprotein: what is the difference? Vessel Plus 2017;1:107-15.

                                         ABSTRACT
            Article history:              Atherosclerosis and related cardiovascular disorders remain the leading global cause of
            Received: 10 Jun 2017         morbidity and mortality. Modified low density lipoprotein (LDL) is considered to play a crucial
            Accepted: 25 Aug 2017         role in atherosclerosis development. During the past decades, several types of atherogenic LDL
            Published: 26 Sep 2017        modification have been discovered. Desialylation was one of the atherogenic modifications
                                          observed in circulating atherogenic LDL in vivo. Sialic acid level negatively correlates with
            Key words:                    triglyceride and cholesterol contents. Desialylated LDL is small, dense and highly susceptible
            Desialylation,                to oxidation, as reported for hyperlipidemic conditions. This atherogenic modification leads to
            desialylated low density lipoprotein,  increased cholesterol intake by macrophages and smooth-muscle cells, and is also associated
            modified low density lipoprotein,   with other pathologies, such as diabetes mellitus. Moreover, these conditions provoke damage
            sialic acid,                  and desialylated LDL particles may trigger autoimmune reactions in macrophages and B-cells.
            atherosclerosis

           INTRODUCTION                                       dendritic cells) and inflammation, followed by necrosis
                                                              and calcification.  Elevated blood pressure, diabetes
                                                                             [2]
           Cardiovascular disease (CVD) is the leading cause of   mellitus, hyperlipidemia, family history and smoking
           morbidity and mortality worldwide. According to the   are the major risk factors of atherosclerosis. These
           American Heart Association, nearly 787,000 people   conditions provoke damage and lipid penetration into
           in the US died from heart disease, stroke or other   the arterial wall. According to current understanding,
           CVDs in 2011.  Atherosclerosis underlies most of the   plasma low density lipoprotein (LDL) plays a crucial
                        [1]
           cardiovascular events in adults. Atherosclerotic plaque   role in the pathogenesis of atherosclerosis because
           formation involves accumulation of cholesterol and its   of its ability to deliver cholesterol from the liver to
           esters in the arterial intima, which results in migration   peripheral tissues, including the arterial wall. On the
           and proliferation of various cell types (smooth muscle   other hand, high density lipoprotein (HDL) negatively
           cells, macrophages, lymphocytes, neutrophils and   correlates with CVD and has protective effects. [3,4]
                                                                                              Quick Response Code:
                       This is an open access article licensed under the terms of Creative Commons Attribution 4.0 International
                       License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution,
            and reproduction in any medium, as long as the original author is credited and the new creations are licensed under the
            identical terms.
            For reprints contact: service@oaepublish.com

                        © 2017 OAE Publishing Inc.  www.oaepublish.com                                    107
   109   110   111   112   113   114   115   116   117   118   119